Overview

* Novanta ( NOVT ) Q3 revenue increased 1.4% to $247.8 mln, beating analyst expectations

* Adjusted EPS for Q3 was $0.87, exceeding analyst estimates

* Adjusted EBITDA for Q3 missed analyst expectations

Outlook

* Novanta expects Q4 2025 GAAP revenue of $253 mln to $257 mln

* Company forecasts full-year 2025 GAAP revenue of $975 mln to $979 mln

* Novanta ( NOVT ) anticipates mid-single digit organic revenue growth in 2026

Result Drivers

* ACQUISITIONS AND CURRENCY - Revenue increase driven by acquisitions and favorable currency exchange rates, offset by negative organic growth

* ADVANCED SURGERY GROWTH - Significant growth in Advanced Surgery business contributed to positive results

* BOOKINGS INCREASE - 17% year-over-year increase in bookings indicates strong demand

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $247.80 $245.95

Revenue mln mln (3

Analysts

)

Q3 Beat $0.87 $0.81 (3

Adjusted Analysts

EPS )

Q3 $10.7

Consolid mln

ated Net

Income

Q3 Miss $58.1 $58.22

Adjusted mln mln (2

EBITDA Analysts

)

Q3 Beat $47.4 $43.67

Adjusted mln mln (2

Operatin Analysts

g Income )

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the electronic equipment & parts peer group is "buy"

* Wall Street's median 12-month price target for Novanta Inc ( NOVT ) is $150.00, about 15.3% above its October 31 closing price of $127.01

* The stock recently traded at 35 times the next 12-month earnings vs. a P/E of 33 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)